Related Experiment Video
Updated: Apr 27, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Pharmacokinetics and toxicity of repeated oral etoposide is altered by morphine coadministration in rats
Makoto Miyazaki1, Tomoko Kawase, Chisako Nishimura
1Department of Pharmaceutics, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan, miyazaki@gly.oups.ac.jp.
Abstract:
The influence of morphine (MOR) on the pharmacokinetics and toxicity of repeated etoposide (ETP) oral administration was evaluated in rats. A decrease in the number of leukocytes in blood was observed by 5 days of treatment with ETP (30 mg/kg/day), which was prolonged by oral MOR coadministration (30 mg/kg/day). Furthermore, MOR significantly decreased animal viability. During the dosing period, the individual plasma ETP concentrations decreased at every dose. These doses were used to estimate the individual pharmacokinetic parameters by the Bayesian method using a linear 2-compartment model with a first-order kinetic absorption and the population parameters reported in our previous study. As a result, repeated ETP dosing without MOR showed a significant decrease in the intestinal absorption rate constant (ka), and single MOR coadministration induced an increase in bioavailability (F) and decrease in ka. However, repeated coadministration of ETP suppressed the increase of F by MOR, and the dose-normalized area under the concentration-time curve was not significantly decreased. The estimated trough concentration in the final day of coadministration was significantly higher than that of the control treatment and indicated a prolonged exposure time. These changes in the absorption of ETP may be closely related to variation in P-glycoprotein (P-gp) activity in the intestine and indicate that the pharmacokinetics and toxicity of ETP are altered by repeated oral coadministration of MOR.
Insights
Morphine (MOR) coadministration alters etoposide (ETP) absorption and toxicity in rats. MOR prolonged ETP-induced leukocyte reduction and decreased animal survival, indicating significant pharmacokinetic and toxicological interactions.
Area of Science:
- Pharmacology
- Toxicology
- Drug Interactions
Background:
- Etoposide (ETP) is a chemotherapy agent with variable oral absorption.
- Morphine (MOR) is an opioid analgesic with potential to affect drug metabolism and transport.
Purpose of the Study:
- To investigate the influence of repeated oral morphine (MOR) on the pharmacokinetics and toxicity of etoposide (ETP) in rats.
- To elucidate the mechanisms underlying ETP-MOR interactions, potentially involving P-glycoprotein (P-gp).
Main Methods:
- Rats received daily oral etoposide (ETP) with or without morphine (MOR) for a defined period.
- Plasma ETP concentrations were measured to estimate pharmacokinetic parameters using Bayesian analysis and a 2-compartment model.
- Leukocyte counts and animal viability were monitored to assess toxicity.
Main Results:
- Morphine (MOR) coadministration prolonged ETP-induced leukopenia and decreased animal viability.
- Repeated ETP dosing with MOR resulted in higher trough ETP concentrations and prolonged exposure compared to ETP alone.
- MOR altered ETP's intestinal absorption rate and bioavailability, suggesting involvement of P-glycoprotein (P-gp).
Conclusions:
- Repeated oral coadministration of morphine (MOR) significantly alters the pharmacokinetics and enhances the toxicity of etoposide (ETP) in rats.
- These interactions are likely mediated by changes in ETP's intestinal absorption, potentially via P-glycoprotein (P-gp) modulation.
- Clinicians should consider potential drug interactions when co-prescribing MOR and ETP, especially with oral administration.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Dosage Regimen: Multiple Oral Dosage
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

